Unacylated Ghrelin Does Not Acutely Affect Substrate Metabolism or Insulin Sensitivity in Men With Type 2 Diabetes | Zendy

Esben Thyssen Vestergaard | Zendy; Niels Jessen | Zendy; Niels Møller | Zendy; Jens Otto Lunde Jørgensen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Unacylated Ghrelin Does Not Acutely Affect Substrate Metabolism or Insulin Sensitivity in Men With Type 2 Diabetes

Author(s) -

Esben Thyssen Vestergaard,

Niels Jessen,

Niels Møller,

Jens Otto Lunde Jørgensen

Publication year - 2019

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-02601

Subject(s) - medicine , endocrinology , lipolysis , insulin , glucose uptake , carbohydrate metabolism , glucose clamp technique , resting energy expenditure , crossover study , type 2 diabetes , ghrelin , placebo , energy expenditure , diabetes mellitus , insulin resistance , pancreatic hormone , adipose tissue , hormone , alternative medicine , pathology

Unacylated ghrelin (UAG) is suggested to improve insulin sensitivity and may have therapeutic potential. We therefore tested the effects of intravenous UAG infusion on glucose and lipid metabolism, insulin sensitivity, and energy expenditure in men with type 2 diabetes mellitus (T2DM).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research